Dr. Amy Kruse leverages her decades of experience as a neuroscientist, her prior roles as an operator and a government program manager, and her network of key relationships to discover transformational companies addressing the largest mental health, brain health, and wellness challenges and opportunities. She also draws on her expertise to support Satori Neuro’s portfolio companies as they evaluate and overcome scientific and implementation challenges, with a specific emphasis on deploying complex technology into real-world environments.

Prior to leading Satori Neuro, Amy was a General Partner at Prime Movers Lab, where she led the fund’s life sciences investments in human augmentation and longevity. She serves on the boards of five Prime Movers Lab portfolio companies: Cognixion, Paradromics, Gilgamesh Pharmaceuticals, Attune Neurosciences and Dimension Inx. She serves on the board of Satori Neuro portfolio companies TARA Mind, Motif Neurotech, Apollo Neuro, Kindly Human and is a Board Observer to Feel Therapeutics and Holobiome.

She previously served as the Chief Scientific Officer of Optios, an applied neuroscience research organization that translates cutting-edge neuroscience discoveries into practical tools to enhance the human experience, and as the Vice President and Chief Technology Officer of Cubic Global Defense, where she oversaw the company’s research and development (R&D) programs. Early in her career, Amy served as a government civilian program manager at the Defense Advanced Research Projects Agency (DARPA), where she created and oversaw the Agency’s first performance-oriented neuroscience programs.

Amy is member of the External Oversight Committee for the NIH Blueprint MedTech program, an advisor to the BrainMind ecosystem, an advisor to the Capital Factory in Texas, and a mentor to the OneMind Accelerator. She is a frequent contributor to defense panels and advisory boards for organizations including DARPA, the National Academies, and the Defense Science Board. She is also the author of numerous scientific papers, chapters, and articles.

Amy earned a Bachelor of Science in Cell and Structural Biology and a PhD in Neuroscience from the University of Illinois Urbana-Champaign, where she was awarded a National Science Foundation Graduate Fellowship.